Nova Mentis (Germany) Today
| HN3Q Stock | EUR 0.02 0.0001 0.57% |
Performance8 of 100
| Odds Of DistressOver 76
|
Nova Mentis is trading at 0.0176 as of the 21st of November 2024. This is a 0.57% increase since the beginning of the trading day. The stock's lowest day price was 0.0176. Nova Mentis has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Nova Mentis has reported 5 for 1 split on 8th of November 2024. Equity ratings for Nova Mentis Life are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of October 2024 and ending today, the 21st of November 2024. Click here to learn more.
Nova Mentis Life Science Corp., through its subsidiaries, engages in the research and development of medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder in Canada. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada. The company has 143.47 M outstanding shares. More on Nova Mentis Life
Moving together with Nova Stock
Moving against Nova Stock
Nova Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Nova Mentis' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Nova Mentis or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Nova Mentis Life (HN3Q) is traded on Frankfurt Exchange in Germany and employs 4 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nova Mentis's market, we take the total number of its shares issued and multiply it by Nova Mentis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nova Mentis Life operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 143.47 M outstanding shares.
Nova Mentis Life has accumulated about 1.51 M in cash with (1.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Nova Mentis Probability Of Bankruptcy
Ownership AllocationNova Mentis Life maintains a total of 143.47 Million outstanding shares. Nova Mentis Life secures 11.73 % of its outstanding shares held by insiders and 0.007 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nova Ownership Details
Nova Mentis Life Risk Profiles
Although Nova Mentis' alpha and beta are two of the key measurements used to evaluate Nova Mentis' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 516.35 | |||
| Semi Deviation | 24.19 | |||
| Standard Deviation | 2129.9 | |||
| Variance | 4536473.09 |
Nova Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nova Mentis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Nova Mentis Corporate Management
Elected by the shareholders, the Nova Mentis' board of directors comprises two types of representatives: Nova Mentis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nova. The board's role is to monitor Nova Mentis' management team and ensure that shareholders' interests are well served. Nova Mentis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nova Mentis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Rascan | CEO Pres | Profile | |
| Kelly Pladson | Co Sec | Profile | |
| Stephen Glazer | Chief Director | Profile | |
| Jacqueline McConnell | COO Director | Profile |
Other Information on Investing in Nova Stock
Nova Mentis financial ratios help investors to determine whether Nova Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Mentis security.